Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Medtronic
MDT
Medtronic
Medtronic Stock: A Compelling Buy for Value and Income Investors as Robotics, Innovation Catalysts Ignite Upside to $105+
EV
Evangelos
Not Invested
Community Contributor
Published
14 Feb 25
Updated
17 Feb 25
21
Set Fair Value
10
votes
5
Share
Evangelos
's Fair Value
US$95.00
2.3% undervalued
intrinsic discount
17 Feb
US$92.81
Loading
1Y
9.4%
7D
0.08%
Author's Valuation
US$95.0
2.3% undervalued
intrinsic discount
Evangelos's Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
Evangelos
's
Fair Value
US$95.0
2.3% undervalued
intrinsic discount
Future estimation in
5 Years
time period
Past
Future
0
42b
2014
2017
2020
2023
2025
2026
2029
2030
Revenue US$42.4b
Earnings US$5.5b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
4.86%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
8.62%
Calculation
US$5.51b
Earnings '30
x
27.57x
PE Ratio '30
=
US$152.02b
Market Cap '30
US$152.02b
Market Cap '30
/
1.08b
No. shares '30
=
US$141.16
Share Price '30
US$141.16
Share Price '30
Discounted to 2025 @ 8.25% p.a.
=
US$94.98
Fair Value '25
